The Food and Drug Administration's decision earlier this week to once again postpone the release of social media guidelines comes as little shock to PR pros.
Although PR execs say that they sympathize with the bureaucratic obstacles the FDA faces, they also stress that by continuing to delay the release of social media guidelines the FDA may hamper the ability of public relations executives to provide proper counsel for their highly regulated clients that want to enhance their social media marketing. ...